CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 41 filers reported holding CATALYST BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17 | -75.4% | 48,633 | -62.9% | 0.00% | -88.9% |
| Q4 2022 | $69 | -99.9% | 131,218 | -30.6% | 0.01% | 0.0% |
| Q3 2022 | $95,000 | -1.0% | 189,175 | +250.5% | 0.01% | +12.5% |
| Q2 2022 | $96,000 | +123.3% | 53,977 | +13.8% | 0.01% | +100.0% |
| Q4 2021 | $43,000 | -64.2% | 47,441 | +63.0% | 0.00% | -63.6% |
| Q3 2021 | $120,000 | -78.9% | 29,103 | +32.3% | 0.01% | -64.5% |
| Q1 2018 | $568,000 | – | 21,997 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
| 22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
| Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
| Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
| Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
| Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
| Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
| AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |